The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation. (CE)
The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Listed as NCT02181374, this observational or N/A phase trial focuses on Ischemic Stroke and remains ongoing. Sponsored by First Affiliated Hospital Xi'an Jiaotong University, it has been updated 11 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Aug 2017 — Feb 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital Xi'an Jiaotong University
- Shaanxi Provincial People's Hospital
- Tang-Du Hospital
- Xijing Hospital
For direct contact, visit the study record on ClinicalTrials.gov .